Supplemental Material - Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Supplemental Material for Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis by Pierre Loiseau, Thomas Foret, Ersilia M DeFilippis, Jessie Risse, Anais D Etienne, Virginie Dufrost, Thomas Moulinet, Doruk Erkan, Hervé Devilliers, Denis Wahl, and Stéphane Zuily in Lupus</p

Supplemental Material - Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Supplemental Material for Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis by Pierre Loiseau, Thomas Foret, Ersilia M DeFilippis, Jessie Risse, Anais D Etienne, Virginie Dufrost, Thomas Moulinet, Doruk Erkan, Hervé Devilliers, Denis Wahl and Stéphane Zuily in Lupus</p

Supplemental Material - Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Supplemental Material for Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis by Pierre Loiseau, Thomas Foret, Ersilia M DeFilippis, Jessie Risse, Anais D Etienne, Virginie Dufrost, Thomas Moulinet, Doruk Erkan, Hervé Devilliers, Denis Wahl and Stéphane Zuily in Lupus</p

Supplemental Material - Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Supplemental Material for Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis by Pierre Loiseau, Thomas Foret, Ersilia M DeFilippis, Jessie Risse, Anais D Etienne, Virginie Dufrost, Thomas Moulinet, Doruk Erkan, Hervé Devilliers, Denis Wahl, and Stéphane Zuily in Lupus</p